Compliance note
SPRAVATO® is a registered trademark of Janssen Pharmaceuticals, Inc. MagVenture is not affiliated with or endorsed by Janssen Pharmaceuticals, Inc.
The MagVenture TMS Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from prior antidepressant medication treatment in the current episode